Polymorphism of Matrix Metalloproteinases Genes MMP1, MMP2, MMP3, and MMP7 and the Risk of Varicose Veins of Lower

A S Shadrina1, M A Smetanina2, K S Sevost'yanova2

  • 1Institute of Chemical Biology and Fundamental Medicine, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia. weiner.alexserg@gmail.com.

Insights

Genetic variations in key matrix metalloproteinase genes do not increase the risk for developing varicose veins in ethnic Russians. These specific gene polymorphisms are not linked to the underlying causes or predisposition of this common vascular condition.

Area of Science:

  • Genetics
  • Vascular Biology
  • Molecular Epidemiology

Background:

  • Varicose veins of the lower extremities represent a prevalent vascular condition with complex etiology.
  • Matrix metalloproteinases (MMPs) are enzymes involved in extracellular matrix remodeling, potentially influencing vascular integrity.
  • Genetic factors, including single nucleotide polymorphisms (SNPs), are investigated for their role in disease susceptibility.

Purpose of the Study:

  • To investigate the association between specific SNPs in MMP1, MMP2, MMP3, and MMP7 promoter regions and the risk of developing lower extremity varicose veins.
  • To determine if these genetic variations serve as markers for varicose vein predisposition in an ethnic Russian population.

Main Methods:

  • Case-control study design involving 536 patients with varicose veins and 273 healthy controls.
  • Genotyping of four specific SNPs: rs1799750 (MMP1), rs243865 (MMP2), rs3025058 (MMP3), and rs11568818 (MMP7).
  • Statistical analysis using logistic regression to assess the association between genotypes and varicose vein risk.

Main Results:

  • No statistically significant association was found between any of the studied MMP gene promoter polymorphisms (rs1799750, rs243865, rs3025058, rs11568818) and the risk of lower extremity varicose veins.
  • The observed frequencies of the studied genotypes did not differ significantly between patients and controls.

Conclusions:

  • The investigated single nucleotide polymorphisms in the promoter regions of MMP1, MMP2, MMP3, and MMP7 are not implicated in the pathogenesis of varicose veins in the studied ethnic Russian cohort.
  • These specific genetic variations do not appear to be reliable markers for predicting predisposition to lower extremity varicose veins.

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
3.5K
Varicose Veins I: Introduction01:26

Varicose Veins I: Introduction

Varicose veins, or varicosities, are abnormally dilated and twisted superficial veins caused by venous valve incompetence. This condition commonly affects the lower extremities, especially the saphenous veins, due to the higher pressure from prolonged standing and walking. However, varicosities can also occur in other areas, such as the esophagus, vulva, spermatic cords, and anorectal region.Etiology and typesPrimary varicose veins, often idiopathic, are more common in women due to inherent...
250
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
1.7K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
24
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
527
The Extracellular Matrix01:29

The Extracellular Matrix

Overview
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
12.6K